People who use injection drugs represent approximately 90% of newly acquired hepatitis C (HCV) infection. Clinicians working with PWID play an important role in reducing HCV-related morbidity and mortality through early diagnosis and treatment.
A new course will strengthen the capacity of clinical staff to test for, treat and manage HCV in their setting. Through online learning and a face-face workshop, delivered by local experts, participants will gain the skills to confidently prescribe the new DAAs.
Date: Saturday, 4 November 2017
Time: 9:00am – 5:00pm (registration from 8:30am)
Breaks – 10:15am, 12:20pm, 2:00pm
Venue: Metropolitan Vancouver Hotel
Address: 645 Howe St, Vancouver, BC V6C 2Y9, Canada
Cost: The course is free of charge; refreshments, morning and
afternoon tea and lunch will be provided.
Speakers: Dr Mark Hull
Register before: Monday, 30 October 2017
Travel scholarships are available.
For further details contact: [email protected]